QQ客服 官方微博 反馈留言

	Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.
	Wang Zhi; Dang Chengxue; Zhu Kun; Zhang Yong; Chang Dongmin; Xia Peng; Song Yongchun; Li Kang
刊名	Molecular and clinical oncology
	2015
卷号	3期号:[db:dc_citation_issue]页码:1088-1092
关键词	deep vein thrombosis fluorouracil cyclophosphamide epirubicin chemotherapy breast cancer D-dimer
ISSN号	2049-9450
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3239316
专题	西安交通大学
推荐引用方式 GB/T 7714	Wang Zhi,Dang Chengxue,Zhu Kun,et al. Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.[J]. Molecular and clinical oncology,2015,3([db:dc_citation_issue]):1088-1092.
APA	Wang Zhi.,Dang Chengxue.,Zhu Kun.,Zhang Yong.,Chang Dongmin.,...&Li Kang.(2015).Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients..Molecular and clinical oncology,3([db:dc_citation_issue]),1088-1092.
MLA	Wang Zhi,et al."Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.".Molecular and clinical oncology 3.[db:dc_citation_issue](2015):1088-1092.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。